We suggest that IL-1α release from infundibular keratinocyte in response to P. acnes-mediated TLR activation is an important step in the complex natural history of the acne lesion (Figure 4). Moreover ...

Pediatric penetrating keratoplasty is technically more challenging than adult keratoplasty because of a smaller anatomical configuration, reduced rigidity and increased elasticity of the cornea and ...

Recently approved tirzepatide joins semaglutide as an option for patients with obesity. Beverly Tchang, MD, offers her recommendations based on her experience for prescribing.

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with ...

Canada can build successful diabetes prevention and remission programs across the country by learning from England and ...

Clinicians caution that while the app flags possible anemia, definitive diagnosis requires lab testing, patient history and ...

Acute dacryocystitis is common in women, and the risk for the condition rises with age, especially in those with primary acquired nasolacrimal duct obstruction.

Two researchers say efforts by the APA to reduce conflicts of interest among DSM-5 panel members fall short, but the APA vigorously defends its disclosure policy.

If you smoke, vape, or ingest cannabis, your anesthesiologist should know before you undergo a surgical procedure, according to new medical guidelines. All patients who undergo procedures that require ...

The US Food and Drug Administration (FDA) has expanded the indication for linaclotide (Linzess) to children as young as age 6 years with functional constipation, making it the first approved treatment ...

May 26, 2010 — The US Food and Drug Administration (FDA) announced yesterday that it has added a warning of suicide risk to the labels of tramadol hydrochloride (Ultram) and tramadol hydrochloride/ ...

This is a very important development. We now have three excellent agents to consider for second-line treatment of our patients, a major advance in the management of ovarian cancer. Today, however, I ...